PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|1|411-417

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.1, 2015-01, pp. : 411-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

microRNA106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells

By        

Oncology Letters, Vol. 7, Iss. 1, 2014-01 ,pp. : 183-188

Spandidos Publications

Access to resources Recommend Favorite

Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1519-1525

Spandidos Publications

Access to resources Recommend Favorite

PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells

By Cheng Haiying  

Carcinogenesis, Vol. 34, Iss. 4, 2013-04 ,pp. : 739-749

Oxford University Press

Access to resources Recommend Favorite

Cisplatin in combination with programmed cell death protein 5 increases antitumor activity in prostate cancer cells by promoting apoptosis

By      

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4561-4566

Spandidos Publications

Access to resources Recommend Favorite

Hyperosmotic stress induces cisplatin sensitivity in ovarian cancer cells by stimulating aquaporin-5 expression

By          

Experimental and Therapeutic Medicine, Vol. 10, Iss. 6, 2015-01 ,pp. : 2055-2062

Spandidos Publications

Access to resources Recommend Favorite